Hans van Houte, Chief Financial Officer at Nurix Therapeutics, Inc. (NRIX), sold 3,130 shares at $12.80 ($40K) on 2025-10-30, disclosed to the SEC on 2025-10-30.
Open-market sale of $40k NRIX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NRIX | SELL | 2026-05-05 | $233K | — | Filing → |
| NRIX | SELL | 2026-04-30 | $40K | — | Filing → |
| NRIX | SELL | 2026-01-30 | $122K | — | Filing → |